Lincoln Pharma Financials

NSE: LINCOLN | BSE: 531633

₹637.50

up-down-arrow-2.30 (-0.36%)

As on 09-Sep-2026IST

Market cap

info icon

₹1,279 Cr

Revenue (TTM)

info icon

₹694 Cr

P/E Ratio

info icon

13.3

P/B Ratio

info icon

1.6

Div. Yield

info icon

0.3 %

Income Statement (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Operating Revenue
694.25
623.23
580.55
510.31
472.12
424.19
Total Income
736.69
645.71
614.97
532.78
482.12
429.85
Total Expenditure
592.94
521.74
480.64
421.11
376.64
337.01
EBITDA
101.31
101.49
99.91
89.20
95.48
87.18
Depreciation
14.91
12.90
10.62
9.17
8.09
7.56
EBIT
86.40
88.59
89.29
80.04
87.39
79.62
Interest
1.06
1.88
1.46
2.03
1.45
1.56
Other Income
42.45
22.48
34.42
22.47
10.00
5.66
Exceptional Items
--
--
--
--
--
--
Profit before Tax
127.79
109.19
122.24
100.48
95.94
83.72
Provision for Tax
31.34
26.84
28.94
27.58
26.58
21.47
Profit after Tax
96.45
82.35
93.30
72.90
69.36
62.25
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
96.45
82.35
93.30
72.90
69.36
62.25

Liabilities (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Shareholder's Funds
757.63
671.67
592.84
502.47
432.88
366.39
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
21.73
19.12
15.18
38.02
10.99
26.10
Current Liabilities
111.05
131.09
117.41
96.01
110.71
94.78
Total Liabilities
890.41
821.88
725.42
636.51
554.58
487.28

Assets (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Non-Current Assets
302.96
297.07
262.51
245.42
181.51
159.59
Current Assets
583.06
524.81
462.91
391.08
373.07
327.69
Total Assets
890.41
821.88
725.42
636.51
554.58
487.28
Total Debt*
--
--
1.07
2.00
2.04
0.52
Net Current Assets
472.01
393.72
345.50
295.07
262.36
232.91
Contingent Liabilities
--
3.12
0.23
0.23
0.23
1.46

Cashflow (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Cash From Operating Activities
--
93.02
63.22
39.26
76.13
69.27
Cash Flow from Investing Activities
--
-78.95
-57.34
-36.64
-78.08
-64.23
Cash from Financing Activities
--
-6.40
-5.18
-4.50
-2.56
-5.75
Net Cash Inflow / Outflow
--
7.67
0.70
-1.88
-4.50
-0.70

Financials Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Adjusted EPS (₹) info
48.15
41.11
46.58
36.40
34.63
31.08
Cash EPS (₹) info
48.15
47.55
51.89
40.97
38.66
34.85
Adjusted Book Value (₹) info
396.34
335.34
295.98
250.86
216.12
182.92
Dividend per Share (₹) info
0.28
1.80
1.80
1.50
1.50
1.50
Cash Flow per Share (₹) info
--
46.44
31.56
19.60
38.01
34.58
Free Cash Flow per Share (₹) info
--
42.52
24.06
18.18
17.14
30.59

Profitability Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
ROCE (%) info
--
17.55
22.53
21.82
24.29
24.90
ROE (%) info
13.09
13.02
17.04
15.59
17.35
18.32
ROA (%) info
11.43
10.64
13.70
12.24
13.31
13.48
EBIT Margin (%) info
12.45
14.22
15.38
15.68
18.51
18.77
Net Margin (%) info
13.09
12.75
15.17
13.68
14.39
14.48
Cash Profit Margin (%) info
--
14.59
17.12
15.35
15.60
15.92

Growth Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Revenue Growth (%) info
10.19
7.35
13.76
8.09
11.30
9.75
EBIT Growth (%) info
-3.37
-0.77
11.55
-8.42
9.76
36.78
Net Profit Growth (%) info
11.70
-11.74
27.99
5.11
11.41
20.95
EPS Growth (%) info
11.70
-11.75
27.99
5.11
11.41
20.84
Book Value Growth (%) info
--
13.30
17.98
16.08
18.15
17.02

Valuation Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Price / Earnings info
13.26
13.42
12.57
9.31
8.98
7.23
Price / Book Value info
1.61
1.64
1.98
1.35
1.44
1.23
Dividend Yield (%) info
0.28
0.33
0.31
0.44
0.48
0.67
EV/EBITDA info
8.70
8.73
8.63
5.79
5.75
4.70
Close Price (₹) info
623.50
551.50
586.05
339.25
310.60
224.85
High Price (₹) info
770.00
979.50
755.15
379.90
414.75
283.45
Low Price (₹) info
439.95
498.00
328.75
255.00
221.30
118.05
Market Cap (₹ Cr) info
1,278.60
1,104.74
1,172.54
678.40
623.02
450.07

Solvency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debt to Equity info
--
--
0.00
0.00
0.00
0.00
Short term debt to equity ratio info
--
--
0.00
0.00
0.00
--
Current Ratio info
5.25
4.00
3.94
4.07
3.37
3.46
Quick Ratio info
4.53
3.40
3.29
3.34
2.71
2.97
Interest Coverage info
121.33
58.99
84.45
50.50
67.11
54.61

Operating Efficiency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debtors to sales (%) info
23.26
26.70
27.86
26.72
24.56
26.72
Asset Turnover info
0.82
0.84
0.89
0.90
0.95
0.95
Receivable days info
--
91.75
89.63
86.09
84.27
89.34
Inventory Days info
--
43.57
44.26
48.72
43.86
39.12
Payable days info
--
141.73
110.27
124.63
138.44
126.82
Cash Conversion Cycle info
--
-6.41
23.61
10.19
-10.30
1.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...